What is Orbem?
Orbem AI, a German deep-tech firm originating from the Technical University of Munich, is at the forefront of developing AI-driven imaging solutions. By integrating accelerated magnetic resonance imaging (MRI) with sophisticated artificial intelligence, Orbem's technology offers non-invasive scanning, classification, and analysis of biological and material samples. This innovative approach reveals internal data crucial for applications in sustainable food systems, quality inspection, and early disease detection, positioning Orbem as a key player in making MRI technology faster, more accessible, and scalable for diverse industrial needs.
How much funding has Orbem raised?
Orbem has raised a total of $96.6M across 2 funding rounds:
Series A
$31.6M
Series B
$65M
Series A (2023): $31.6M with participation from Possible Ventures, La Famiglia, 83North, and The Venture Collective
Series B (2026): $65M led by 83North, Innovation Industries, General Catalyst, Possible Ventures, The Venture Collective, and Supernova Invest
Key Investors in Orbem
83North
83North is a global venture capital firm that invests in exceptional entrepreneurs across all stages, focusing on building category-leading companies. They have a diverse portfolio and a track record of successful exits and unicorns, supporting startups in scaling globally.
Innovation Industries
Innovation Industries is a European venture capital fund specializing in impactful deep tech companies focused on sustainability and scalability. They invest in groundbreaking technologies addressing global challenges and aim to maximize environmental, social, and economic impact.
General Catalyst
General Catalyst is a venture capital firm that backs transformational business opportunities across multiple sectors and stages, supporting entrepreneurs with capital and operational expertise to build enduring enterprises.
What's next for Orbem?
The substantial enterprise-level funding Orbem has garnered, particularly its recent strategic investment, signals a strong market validation and positions the company for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, enhance its AI capabilities, and expand its operational reach into critical sectors like food sustainability and healthcare diagnostics. Orbem's trajectory suggests a move towards scaling its unique imaging technology, aiming to establish new industry standards for data analysis and efficiency.
See full Orbem company page
